As of 02 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS) for possible financing by the Department of Health (DOH) and/or the Philippine Health Insurance Corporation (PhilHealth). The HTA Council continue reading : HTA Council Preliminary Recommendation on ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS)
HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b
As of 05 March 2025, the Health Technology Assessment (HTA) Council makes public its preliminary recommendation on the non-inclusion in the PNF and thus the non-government financing of hexavalent vaccine, for stakeholder feedback/comments. Overall, the HTA Council recognizes that hexavalent vaccines will result in a simpler immunization schedule and thus, better compliance and easier implementation. continue reading : HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b
HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above
Update as of 19 March 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above ended on 12 March 2024 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to continue reading : HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above
HTA Council Preliminary Recommendation on High-risk Human Papillomavirus (HPV) DNA Test and Visual Inspection with Acetic Acid
Update as of 13 March 2025: The public consultation and appeals period for the HTA Council’s Preliminary Recommendation on the (1) High-Risk Human Papillomavirus (HrHPV) DNA Test and (2) Visual Inspection with Acetic Acid (VIA) for cervical cancer screening in women aged 30–65 years ended on 25 February 2025. HTA Philippines received and processed one continue reading : HTA Council Preliminary Recommendation on High-risk Human Papillomavirus (HPV) DNA Test and Visual Inspection with Acetic Acid